Tyrosinase (TYR) (NM_000372) Human Mass Spec Standard

CAT#: PH321797

TYR MS Standard C13 and N15-labeled recombinant protein (NP_000363)



  View other "Tyrosinase" proteins (4)

Need it in bulk or customized?
Get a free quote

CNY 14,250.00


货期*
5周

规格
    • 10 ug

Product images

经常一起买 (2)
Transient overexpression lysate of tyrosinase (affected in oculocutaneous albinism IA) (TYR)
    • 100 ug

CNY 4,840.00


TYR mouse monoclonal antibody, clone OTI1F3 (formerly 1F3)
    • 100 ul

CNY 1,999.00
CNY 2,700.00

Specifications

Product Data
Description TYR MS Standard C13 and N15-labeled recombinant protein (NP_000363)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC221797
Predicted MW 60.39 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_000363
RefSeq Size 1964
RefSeq ORF 1587
Synonyms ATN; CMM8; OCA1; OCA1A; OCAIA; SHEP3
Locus ID 7299
Cytogenetics 11q14.3
Summary The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. [provided by RefSeq, Oct 2008]
Protein Families Transmembrane
Protein Pathways Melanogenesis, Metabolic pathways, Riboflavin metabolism, Tyrosine metabolism
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...